Treating Biliary Tract Cancers: New Targets and Therapies Joseph HoConstance FioccoKristen Spencer Leading Article 28 November 2022 Pages: 1629 - 1647
Therapeutic Landscape Beyond Immunotherapy in Advanced Urothelial Carcinoma: Moving Past the Checkpoint Abhishek TripathiKira MacDougallGuru P. Sonpavde Review Article 28 November 2022 Pages: 1649 - 1662
Teprotumumab: A Review in Thyroid Eye Disease Tina NieYvette N. Lamb Adis Drug Evaluation Open access 23 November 2022 Pages: 1663 - 1670
Deucravacitinib: First Approval Sheridan M. Hoy AdisInsight Report 19 November 2022 Pages: 1671 - 1679
Spesolimab: First Approval Hannah A. Blair AdisInsight Report Open access 23 November 2022 Pages: 1681 - 1686
Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids Yahiya Y. Syed Correction Open access 23 November 2022 Pages: 1687 - 1687
Correction to: Valemetostat Tosilate: First Approval Susan J. Keam Correction Open access 28 November 2022 Pages: 1689 - 1689